MANINI, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 5.019
NA - Nord America 4.375
AS - Asia 2.042
SA - Sud America 459
AF - Africa 63
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.967
Nazione #
US - Stati Uniti d'America 4.312
GB - Regno Unito 1.729
RU - Federazione Russa 991
CN - Cina 775
SG - Singapore 623
IE - Irlanda 581
IT - Italia 575
BR - Brasile 391
SE - Svezia 266
UA - Ucraina 235
DE - Germania 212
HK - Hong Kong 176
VN - Vietnam 175
FR - Francia 171
KR - Corea 117
FI - Finlandia 106
IN - India 48
AR - Argentina 40
CA - Canada 36
ES - Italia 33
CI - Costa d'Avorio 27
AT - Austria 25
BD - Bangladesh 23
PL - Polonia 21
MX - Messico 18
BE - Belgio 16
JP - Giappone 14
NL - Olanda 12
TR - Turchia 12
ZA - Sudafrica 12
CZ - Repubblica Ceca 10
ID - Indonesia 10
IQ - Iraq 10
MA - Marocco 10
EC - Ecuador 8
LT - Lituania 7
PK - Pakistan 7
CO - Colombia 5
IL - Israele 5
IR - Iran 5
UZ - Uzbekistan 5
AL - Albania 4
AU - Australia 4
AZ - Azerbaigian 4
JO - Giordania 4
OM - Oman 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
VE - Venezuela 3
BY - Bielorussia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
KE - Kenya 2
KW - Kuwait 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 11.967
Città #
Southend 1.612
Dublin 580
Dallas 570
Fairfield 451
Singapore 342
Ashburn 301
Chandler 288
Santa Clara 283
Moscow 245
Woodbridge 230
Beijing 214
Houston 206
Siena 204
Wilmington 198
Jacksonville 193
Seattle 190
Hong Kong 173
Cambridge 168
Hefei 119
Seoul 117
Ann Arbor 109
Princeton 89
Dong Ket 77
Nanjing 70
Munich 65
Los Angeles 58
Ho Chi Minh City 39
San Mateo 39
Helsinki 38
New York 38
São Paulo 36
Boardman 34
Milan 32
Buffalo 31
San Diego 29
Abidjan 27
Lappeenranta 27
Nanchang 25
Florence 24
The Dalles 24
Council Bluffs 23
Málaga 23
Redondo Beach 23
Bengaluru 21
Shenyang 21
Rome 20
Toronto 19
Warsaw 18
Hanoi 17
Tianjin 17
Vienna 16
Brussels 15
Kunming 15
Rio de Janeiro 15
Hebei 14
Phoenix 14
Shanghai 14
Tokyo 14
Denver 13
Norwalk 13
Nuremberg 13
Dearborn 12
Frankfurt am Main 12
London 12
San Francisco 11
Turku 11
Brasília 10
Chicago 10
Hangzhou 10
Stockholm 10
Belo Horizonte 9
Brooklyn 9
Fremont 9
Guangzhou 9
Jinan 9
Curitiba 8
Poplar 8
Taizhou 8
Chennai 7
Columbus 7
Jiaxing 7
Manchester 7
Messina 7
Montreal 7
Mumbai 7
Orem 7
Turin 7
Atlanta 6
Boston 6
Da Nang 6
Dhaka 6
Fuzhou 6
Haikou 6
Johannesburg 6
Pontedera 6
Auburn Hills 5
Baghdad 5
Brescia 5
Charlotte 5
Düsseldorf 5
Totale 8.256
Nome #
"OKKIO alla salute 2014" results from the Tuscan sample 647
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 516
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 473
Egg-Independent Influenza Vaccines and Vaccine Candidates 297
Constant expression of hexose-6-phosphate dehydrogenase during differentiation of human adipose-derived mesenchymal stem cells 277
Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2 273
A method for detection of neuraminidase antibody in serum 265
Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression 258
Flucelvax (Optaflu) for seasonal influenza 256
Challenges in the development of egg-independent vaccines for influenza 255
Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season 246
Moderate vaccine effectiveness against severe acute respiratory infection caused by a(H1N1)pdm09 influenza virus and no effectiveness against a(H3N2) influenza virus in the 2018/2019 season in Italy 229
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 224
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 223
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season 215
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice 213
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 208
Immunogenicity and safety of the new inactivated quadrivalent influenza vaccine vaxigrip tetra: Preliminary results in children ≥6 months and older adults 207
Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development 206
RT-PCR multiplex per l’identificazione simultanea di influenza virus A/H1N1 A/H3N2 e B e Virus Respiratorio Sinciziale di tipo A e B 185
Mapping host-related correlates of influenza vaccine-induced immune response: An umbrella review of the available systematic reviews and meta-analyses 181
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? 179
CORRELATES OF PROTECTION AND HOST-RELATED MODIFIERS OF THE IMMUNOGENICITY OF INFLUENZA VACCINES: EVIDENCE MAPS AND EVIDENCE GAPS 175
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy 173
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells 169
Pre-emptive vaccination against pandemic influenza virus 168
Hepatitis A infection in central Tuscany in children and youths 168
Safety, tolerability and immunogenicity of a mammalian cell culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial 168
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 165
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 164
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 162
Hepatitis A seroprevalence in Tuscany, Italy 157
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany 151
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 151
Evaluation of maternal perception of children's weight and body mass index in tuscany, Italy 142
Effetti dell’ozono sui microrganismi 141
La vaccinazione influenzale e l’eterovarianza dei ceppi circolanti: uno studio comparativo 140
Epidemiology and prevention of Human Papillomavirus 140
Epidemiological and virological surveillance of Severe Acute Respiratory Infections in the 2019/2020 season in Siena, Tuscany, Italy 138
Use of pseudotyped particles expressing influenza A/Viet Nam/1194/2004 haemagglutinin in immunological assays 136
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 135
Validation of Single Radial Haemolysis assay for detection of H5 influenza antibodies 131
Trend della prevalenza di sovrappeso e obesità nei bambini toscani in età scolare dal 2002 al 2016 [Trends of overweight and obesity prevalence among schoolchildren in Tuscany Region (Central Italy), period 2002-2016] 131
Sieroepidemiologia della varicella in donne in età fertile 129
Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap? 128
Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials 126
Surveillance of Influenza and Other Airborne Transmission Viruses during the 2021/2022 Season in Hospitalized Subjects in Tuscany, Italy 124
There is a correlation between nutritional status, Self-Rated Health and Life Satisfaction? Evidence from 2018 Health Behaviour in School-aged Children cross sectional study in a sample of Italian adolescents living in Tuscany Region 123
Trend of Correlations between Psychological Symptoms and Socioeconomic Inequalities among Italian Adolescents: Cross-Sectional Study from 2006 to 2018 in Tuscany Region 121
Trend of accesses to the ED of Teaching Hospital of Tuscany for bronchiolitis 2018-2023: new emergency 116
null 116
Real time PCR per la diagnosi simultanea di virus influenzali di tipo A 115
Lower frequency of SARS-CoV-2-associated severe respiratory infections among adults vaccinated against the 2021/22 season influenza 114
Risultati e prospettive del Piano Regionale per l'Eliminazione del Morbillo e della Rosolia Congenita in Toscana. 111
Sicurezza e risposta immunitaria di un vaccino antinfluenzale prodotto in cellule MDCK in Soggetti Adulti ed Anziani Sani 109
Valutazione microbiologica dell’aria di uno stabulario 109
Sieroprevalenza dell'epatite A in Toscana in bambini e giovani adulti 107
Valutazione dell’immunogenicità di due vaccini antinfluenzali a confronto 105
Usability of SRH assay to titration H5 antigen 104
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 103
Sorveglianza virologica della nuova variante del virus influenzale A/H1N1 nell’Area Vasta Toscana sud 100
Seroepidemiology of Influenza A/H5N1 Virus in the Italian Population Since from 1992 until to 2007 99
How Family Structure Can Influence Adolescents’ Eating Habits: An Italian Health Behaviour in School-Aged Children (HBSC) 2022 Sample 97
Seroepidemiology of influenza A/H5N1 virus in the Italian population from 1992 to 2007 92
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 92
Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection 89
Surveillance of Severe Acute Respiratory Infection and Influenza Vaccine Effectiveness among Hospitalized Italian Adults, 2021/22 Season 83
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 71
Relative effectiveness of the adjuvanted vs non-adjuvanted seasonal influenza vaccines against severe laboratory-confirmed influenza among hospitalized Italian older adults 65
Influenza D Virus: A Potential Threat for Humans? 53
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm) 52
SARS-CoV-2, influenza, HRSV and other respiratory pathogens during the post-COVID-19 era: Epidemic circulation in Italy in the 2023/2024 season 36
Totale 12.127
Categoria #
all - tutte 37.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.023 0 0 0 0 0 154 87 173 128 204 132 145
2021/2022798 71 113 81 83 25 15 29 44 63 52 75 147
2022/20231.059 63 87 145 148 93 212 39 87 95 30 33 27
2023/2024893 36 28 44 37 51 203 327 26 8 34 29 70
2024/20251.984 50 111 221 101 277 117 85 80 163 69 196 514
2025/20263.030 380 587 529 639 853 42 0 0 0 0 0 0
Totale 12.127